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Abstract
Aluminum oxide based optically stimulated luminescent dosimeters (OSLD) have
been recognized as a useful dosimeter for measuring CT dose, particularly for
patient dose measurements. Despite the increasing use of this dosimeter, appropri-
ate dosimeter calibration techniques have not been established in the literature;
while the manufacturer offers a calibration procedure, it is known to have relatively
large uncertainties. The purpose of this work was to evaluate two clinical
approaches for calibrating these dosimeters for CT applications, and to determine
the uncertainty associated with measurements using these techniques. Three unique
calibration procedures were used to calculate dose for a range of CT conditions
using a commercially available OSLD and reader. The three calibration procedures
included calibration (a) using the vendor‐provided method, (b) relative to a 120 kVp
CT spectrum in air, and (c) relative to a megavoltage beam (implemented with 60Co).
The dose measured using each of these approaches was compared to dose mea-
sured using a calibrated farmer‐type ion chamber. Finally, the uncertainty in the
dose measured using each approach was determined. For the CT and megavoltage
calibration methods, the dose measured using the OSLD nanoDot was within 5% of
the dose measured using an ion chamber for a wide range of different CT scan
parameters (80–140 kVp, and with measurements at a range of positions). When
calibrated using the vendor‐recommended protocol, the OSLD measured doses were
on average 15.5% lower than ion chamber doses. Two clinical calibration techniques
have been evaluated and are presented in this work as alternatives to the vendor‐
provided calibration approach. These techniques provide high precision for OSLD‐
based measurements in a CT environment.
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1 | INTRODUCTION
The nanoDot optically stimulated luminescent dosimeter (OSLD)
(Landauer Inc, Glenwood, IL, USA), is a common detector for point
dosimetry, particularly in therapeutic applications.1–7 More recently,
in conjunction with the increased interest in improved computed
tomography (CT) dosimetry, there has been interest in using the
nanoDot for this purpose. Several recent studies have used OSLD in
this capacity,8–14 including a few in‐depth evaluations of the dosime-
ter characteristics in a CT environment.15–18 Importantly, no studies
to date explore or describe calibration procedures for OSL‐based
dosimetry in a CT environment. This is not just practically useful
information when conducting these measurements, but is particularly
relevant in the context of dosimetric uncertainty. While the AAPM
TG‐191 report19 details dosimetric uncertainty associated with more
common applications, the uncertainty of OSLD measurements in CT
dosimetry has not yet been quantified.
The general formalism for calculating dose using this dosimeter is
shown in eq. (1),19 where the absorbed dose, D, at the location of
the OSLD is equal to product of the average corrected signal reading
(Mcorr), the calibration coefficient (ND,W), and any additional necessary
correction factors (k).
D ¼ Mcorr  ND;W  kL  kF  kG  kθ  kQ (1)
The average corrected signal, Mcorr , accounts for signal depletion
(kd; determined during commissioning), the number of readings of
the detector (J), background if necessary (Mbkg), and, if a batch cali-
bration approach is used, the unique element sensitivity (ks,i), as
shown in eq. (2):
Mcorr ¼ ks;i 
∑
j
Mraw;j;i  kj1d
 
J
Mbkg
2
664
3
775 (2)
Correction factors are typically necessary depending on the
application, and include linearity (kL), fading (kF), and beam quality
(kQ) which are standard and defined elsewhere.
19 Angular depen-
dence (kθ) describes the difference in signal in a CT environment as
the angle of the detector is changed from lying flat in the bore, and
the irradiation geometry correction (kG) accounts for the difference
between a static en‐face irradiation and an irradiation based on a
source rotating around the face of the detector.18
The calibration procedure determines the value of ND,W, and
thereby establishes the relationship between the OSLD signal and
dose. A common calibration procedure used clinically is that offered
by the vendor, through pre‐irradiated dosimeters which are provided
with the OSLD reader.15,16 This set of 15 dosimeters are irradiated
by the vendor in an 80 kVp beam to five known dose levels, and a
calibration coefficient as a function of dose is determined for all
future reading sessions. However, this is not an ideal calibration for
several reasons. First, irradiation of calibration dosimeters is left
solely to the vendor. Second, by performing only one calibration,
instability or fluctuations in the OSLD reader are ignored, and drift
in the reader over time is not accounted for. Third, variations in
OSLD sensitivity between dosimeter production batches are
neglected. Fourth, the vendor‐supplied calibration defines the
dosimeter response relative to solely an 80 kVp beam. One of the
main challenges in performing dosimetry using OSLD in diagnostic
imaging is that the response of the dosimeter is very sensitive to
changes in beam quality.20–22 Calibrating the dosimeter with a higher
or lower energy than that being used for experimental measure-
ments can introduce large errors into dose measurement unless
appropriate energy correction factors (kQ) are used. However, the
vendor calibration protocol does not address differences in energy
between different scan parameters. Therefore, an alternative
approach to OSLD calibration for CT measurements is desired. One
approach was recently implemented by Stepusin et al.,12 where the
OSLD readings at each energy and depth were cross‐calibrated with
ion chamber measurements at each location to determine appropri-
ate beam quality correction factors. Nevertheless, a systematic eval-
uation of calibration techniques, and associated uncertainties, is
necessary.
The purpose of this investigation was, first, to present three
calibration protocols: the vendor calibration procedure, a calibration
using a 120 kVp CT beam and ion chamber, and a calibration using
a megavoltage beamline (in this study using a 60Co beam) as would
be reasonable for diagnostic procedures conducted at radiotherapy
facilities). Second, we evaluated and contrasted the accuracy of
these three protocols, particularly the suitability of the vendor cali-
bration procedure. Third, we rigorously established the uncertainty
associated with each protocol. To facilitate these three steps, we
performed a range of CT dose measurements in different scans
and at different locations, and assessed the dose determined with
each of the three protocols. These doses were compared to the
dose determined at these same locations with a calibrated ion
chamber to validate the accuracy of the three different calibration
approaches.
2 | CALIBRATION FORMALISM
2.A | Dosimeters
This work used the nanoDot OSL dosimeters and the InLight microS-
tar OSL reader (Landauer, Inc., Glenwood, IL, USA). The aluminum
oxide based dosimeter (Al2O3:C) has a disk‐shaped active volume
4 mm in diameter and 0.3 mm thick, and is enclosed in a light‐tight
plastic cassette measuring 10 mm × 10 mm × 2 mm. The inLight
microStar OSL reader was operated in continuous mode for a 7‐s
read time, using the strong LED setting (for low doses). For this read
time and LED intensity, the depletion was approximately 1.6% per
reading,18 and this correction was applied to all subsequent readings.
The relative element sensitivity was determined for each dosimeter
by irradiating them all to 25 cGy and measuring their relative signals.
These dosimeters were then bleached and used for the experiments
described below. The derived element sensitivity correction factors
were applied to all measurements.
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Absolute dose in CT measurements was also measured with a
RadCal (Monrovia, CA, USA) 10 × 5−0.6 CT ion chamber (farmer
chamber style) with an active volume of 0.6 cm3. The chamber was
previously calibrated in a 120 kVp beam by an accredited dose cali-
bration lab (ADCL). The farmer‐type ion chamber was used in con-
junction with a RadCal 9010 series electrometer, operated in
autoexposure mode. To convert the measured exposure readings to
absorbed dose using the ion chamber, we used the American Associ-
ation of Physicists in Medicine (AAPM) task group (TG) report 111
protocol23 [eq. (3)] using the chamber reading (q), the calibration
coefficient (Nk), and appropriate corrections for temperature and
pressure effects (PTP) and the electrometer factor (Pelec). The ratio of
mass energy absorption coefficients was also applied to define the
dose to the medium of choice; for this work the medium selected
was water.
Dwater ¼ kair μenρ
 water
air
¼ qPTPPelecNk μenρ
 water
air
(3)
2.B | Calibration protocols
Optically stimulated luminescent dosimeter calibration establishes
the relationship between dosimeter signal and dose using “stan-
dards” (i.e., OSLD irradiated to a known dose). For each of the three
calibration procedures investigated, the OSLD calibration coefficient
was defined using these “standards” as the ratio of the known dose
to the OSLD signal (measured in counts) as shown in eq. (4).
ND;W ¼ Delivered Dose ðmGyÞOSLD signal ðcountsÞ (4)
Water was selected as the reference medium for defining dose
to the standard dosimeters using both the CT‐based calibration and
the megavoltage‐based calibration. As a result, the absorbed dose
calculated using the dosimeters and these protocols is dose to water,
regardless of the actual measurement medium.
The process to determine this calibration coefficient for each of
the three calibration protocols is described below:
2.B.1 | Vendor calibration protocol
This protocol used pre‐irradiated dosimeters provided by the
dosimeter vendor. Calibration dosimeters are irradiated by the manu-
facturer on a PMMA phantom using 80 kVp x rays (2.9 mm Al HVL)
to known delivered dose levels of approximately 0, 3, and 20 mGy.
The two‐sigma uncertainty on the dose delivered to the dosimeters
is reported to be ±5%.24
In this work, the calibration dosimeters were read three times
each, and the average of the depletion‐corrected signal was used to
establish the calibration factor: ND,Vendor. An adjustment for the dif-
ference in sensitivity in the vendor‐supplied dosimeters and the
experimental dosimeters was also made (as these dots came from
different production batches), despite the fact that correcting for this
difference is not explicitly advised in the vendor calibration proce-
dures: the calibration dosimeters had a mean inherent sensitivity of
0.85 while the experimental dots had a mean inherent sensitivity of
0.93. A uniform factor of the ratio of these (1.094) was therefore
applied to the calibration factor to account for this difference.
2.B.2 | Free‐in‐air CT calibration protocol
This calibration protocol relates the dose measured using a calibrated
ion chamber to the OSLD signal for dosimeters irradiated under
identical conditions using a CT scanner as the radiation source.
In this work, the ion chamber and OSLD standards were irradi-
ated free‐in‐air using a 120kVp CT beam (Discovery CT750 HD,
GE Healthcare; Milwaukee, WI, USA). All calibration measurements
were performed with a rotating CT tube using the medium bowtie
filter and 64 × 0.625 mm detector configuration to provide a
~40 mm beam width at isocenter. The beam at this location had a
measured HVL of 6.54 mm Al and a mean spectral energy of
59.9 keV (based on previous Monte Carlo simulations).18 No table
motion was allowed during irradiation. Two nanoDots were posi-
tioned at isocenter using a piece of tape suspended through the
CT bore (although any minimally attenuating support system would
work). The OSLD were located at the machine isocenter using laser
alignment lights, and the 40 mm beam width completely covered
both dosimeters [Fig. 1(a)]. A single axial rotation was used to deli-
ver 140 mA with a 1‐s rotation time. This procedure was repeated
two additional times with new dosimeters, such that six total
dosimeters were irradiated in the same fashion. Each of the six
OSLDs was read three times, and the average (depletion and
element sensitivity‐corrected) signal was used to describe the
dosimeter signal.
The calibrated ion chamber was used to measure dose under
identical conditions and scanning technique. The ion chamber was
positioned on an empty cardboard box and aligned such that the
active volume intersected the machine isocenter using laser align-
ment lights, and with the entirety of the chamber's active volume
covered by the 40 mm beam [Fig. 1(b)]. This procedure was repeated
two additional times to acquire three readings using the ion
chamber.
The delivered dose (to water) was defined using the average of
the ion chamber measurements [described in eq. (3)]. Per eq. (4), the
calibration factor for the CT calibration (ND,CT) was the ratio of dose
to signal.
2.B.3 | Calibration using megavoltage beam
The third calibration protocol used a 60Co beamline to determine
dose (although a 6 MV beam could also be used), and followed the
general procedure used for OSLD calibration by IROC Houston and
other radiotherapy auditing bodies.3,5,6 This procedure relies on
megavoltage equipment, and would therefore be most applicable to
radiotherapy environments. One advantage of this protocol is the
very high accuracy of the delivered dose to the calibration (standard)
SCARBORO ET AL. | 333
OSLDs by virtue of the high precision and stability in the clinical ref-
erence dosimetry of megavoltage beams.
In this work, irradiations were performed using a Theratron 780C
cobalt unit (AECL/Theratronics International Ltd., Kanata, ON,
Canada), which is maintained by an ADCL at The MD Anderson Can-
cer Center (Houston, TX, USA). Two dosimeters were simultaneously
irradiated in a Lucite block approximately 4 cm × 4 cm × 4 cm in
dimension [Fig. 2(a)], positioned in a jig to minimize setup uncer-
tainty [Fig. 2(b)], and located at a distance of 80 cm from the cobalt
source. The beam energy at the in‐air location of the calibration
measurements was taken as 1.25 MeV.
The dose delivered to the dosimeters (45 mGy) was determined
based on a decay‐correction of the dose rate of the source and the
TG‐51 calibration protocol.25
Four dosimeters were irradiated using the 60Co unit. Each of the
four dosimeters was read three times, and the average (depletion
and element sensitivity‐corrected) signal was used to describe the
dosimeter signal. This OSLD signal was compared to the delivered
dose with the cobalt beam based on the timer setting and the calcu-
lated dose rate. This yielded the calibration coefficient for the 60Co
calibration protocol: ND,60Co.
2.C | Correction factors (ki)
Because the conditions of these calibration irradiations will not be
identical to the conditions of the irradiation of experimental OSLD,
correction factors to the measured signal are necessary. The neces-
sary correction factors for each of the above calibration protocols
are described below in the context of the test measurements used
to evaluate the accuracy of the different calibration procedures.
2.D | Test measurements
A set of measurements was performed to compare the results of the
three calibration protocols with the dose measured using a RadCal
10 × 5 CT farmer‐type ion chamber. All measurements were per-
formed using a 64‐slice CT scanner (Discovery CT750 HD, GE
Healthcare, Milwaukee, WI, USA) and standard acrylic CT Dose
Index (CTDI) phantoms (32 and 16 cm in diameter). The half value
layer of the 80, 120, and 140 kVp beams (with medium bowtie filter)
were 4.27, 6.54, and 7.62 mm Al, respectively. The OSLD were
placed in the center, the periphery, and on the surface of the large
CTDI phantom and in the center and on the surface of the small
(a) (b)
F I G . 1 . (a) OSLD setup for free‐in‐air CT
calibration; (b) ion chamber setup using
empty cardboard box for free‐in‐air
calibration
(a) (b)
F I G . 2 . (a) Acrylic block with 2 OSLD
used for irradiating OSLD standards in
60Co Calibration Protocol (b) 60Co unit
used for irradiation of standards in the
acrylic block.
334 | SCARBORO ET AL.
CTDI phantom. For each measurement location, two OSLD were
irradiated, and the irradiation was repeated three times for a total of
six dosimeters at each location. The irradiation was then repeated
with the farmer‐type ion chamber in the same location as the OSLD.
The OSLD were read three times and the average (depletion and
element sensitivity‐corrected) value was used as the corrected OSLD
signal. This same signal was converted to dose using the three differ-
ent calibration protocols described above, so any differences in mea-
sured dose for a given condition reflect differences in the calibration
protocol (including associated correction factors).
The CT‐scanning techniques used to compare the calibration
protocols were selected to represent a range of energy spectra.
Eleven unique measurement conditions were used for this compar-
ison; the scanning parameters and dosimeter position for these 11
cases are shown in Table 1. All scans used a 40 mm beamwidth
and either axial or helical scans, depending on scan extent (as
shown in Table 1). All helical scans used a pitch of 0.984. Expo-
sures ranged from 200 to 900 mAs with either 1 or 2 s rotations
times, such that the dose delivered to the ion chamber at the
same position was between 25 and 40 mGy. Each of these condi-
tions was also simulated using a previously benchmarked Monte
Carlo model based on the same x‐ray source and geometry26; the
mean spectral energy at the position of the dosimeter was deter-
mined (Table 1).
The dose to the OSLD was determined using eqs. (1) and (2). For
most uses in a CT environment, kL (linearity correction) is unity.
18 All
dosimeters were placed flat relative to the CT bore so that there
was no angular dependence, and all times were controlled so there
was no relative fading between the standards and experimental
detectors. Other possible corrections are described below:
For the vendor‐recommended calibration procedure, the dose
was determined using the manufacturer‐provided approach, as
shown in eq. (5), and using the energy correction provided by the
vendor (kQ, Vendor), which the vendor states is equal to 1.19 for all CT
measurements. Other possible correction factors were ignored as no
other corrections are suggested by the vendor.
DVendor ¼ Mcorr  ND;Vendor  kQ;Vendor (5)
For CT calibration and dosimetry, the value of kG is unity
because there is no difference in irradiation geometry between the
standards and experimental OSLD. The dose to the OSLD was there-
fore calculated using eq. (6).
DCT ¼ Mcorr  ND;CT  kQ;CT (6)
Values for kQ,CT were previously determined using the simulated
photon energy spectra and Burlin cavity theory,18 and are provided
in Table 2.
For the megavoltage calibration technique, kG is necessary to
account for the differences in irradiation geometry between the cali-
bration conditions (static en‐face irradiation of the dosimeter) and
the measurement conditions (rotating irradiation), but has a relatively
small value of 1.03.18 The dose to the OSLD for dosimeters follow-
ing the 60Co calibration protocol was determined using eq. (7), where
the energy correction factors are shown Table 2.
D60Co ¼ Mcorr  ND;60Co  kG  kQ;60Co (7)
2.E | Uncertainty analysis
Although eqs. (5–7) are of similar form, the components of each are
derived from different sources or have a different impact on the
total uncertainty and therefore each calibration protocol has a differ-
ent overall uncertainty. The total uncertainty of the determined dose
was therefore calculated for each calibration protocol. This was
based on the uncertainty in the underlying factors: the uncertainty
in the factors kL, kF, kG, kθ, and kQ were taken from Scarboro et al.
18
(except for the uncertainty in the vendor‐recommended CT energy
correction factor, which was estimated based on the actual mea-
sured energy correction factors for the range of measurement condi-
tions investigated). The variance in the raw count rate was taken
from the measurements in the current study. The variance in each
TAB L E 1 Measurement conditions for calibration protocol validation measurements.
Measurement
position
CTDI
phantom Position kVp
Scan
extent (mm)
Scan
Type
Mean spectral
energy (keV)
1 16 cm Center 80 40 Axial 45.4
2 16 cm Surface 80 150 Helical 47.9
3 32 cm Center 120 150 Helical 51.7
4 32 cm Center 120 40 Axial 54.7
5 16 cm Center 120 40 Axial 55.3
6 16 cm Center 140 40 Axial 58.1
7 32 cm Center 140 40 Axial 58.7
8 32 cm Periphery 120 40 Axial 59.5
9 32 cm Surface 120 150 Helical 60.7
10 16 cm Surface 140 150 Helical 63.2
11 16 cm Surface 140 40 Axial 64.9
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ND was determined from the uncertainty in each of its parameters
(i.e., the parameters in eq. (1) rearranged to solve for ND), including
the uncertainty in the reference dose associated with each calibra-
tion protocol (±5% for the vendor calibration,24 ±5% for the CT pro-
tocol,27 and 0.9% for the MV protocol28).
Rather than simply combining these component uncertainties in
quadrature, the total uncertainty was determined more robustly
using eqs. (8) and (9), where var denotes variance and E denotes the
expected value (i.e., the mean).
varðXYÞ ¼ varðXÞvarðYÞ þ varðXÞEðYÞ2 þ varðYÞEðXÞ2 (8)
In eq. (8), X represented a given factor (e.g., Mcorr ), and Y repre-
sented the product of the remaining factors (ND × kL × kF × kG × kθ
× kQ). The variance of Y was calculated by applying eq. (8) recur-
sively to each individual factor (X’ = ND, and Y’ = kL × kF × kG × kθ ×
kQ and so on). Calculation of the variance of Mcorr also required
eq. (9), as Mcorr is a linear combination of products of correlated vari-
ables [eq. (2)]. In this case, CoV is the covariance between X and Y:
varðX þ YÞ ¼ varðXÞ þ varðYÞ þ 2CoVðX;YÞ (9)
This method is more robust than adding uncertainties in quadra-
ture because it does not rely on the normality assumption of the dis-
tribution, or on any type of mathematical approximation, and
allowed us to analytically determine the standard deviation of the
OSLD measured dose.
3 | RESULTS AND DISCUSSION
3.A | Comparison of calibration methods
For a range of measurement conditions, varying measurement posi-
tion, phantom size, kVp, and scan extent, the dose to the OSLD was
determined using each of three calibration protocols. These values
were then compared to the dose measured using the farmer‐type CT
ion chamber and plotted as a function of the mean photon energy
for the scan parameters selected (Fig. 3).
The error bars in Fig. 3 represent the relative uncertainty for
each method, as calculated in eqs. (8) and (9). A comparison of the
measured doses is provided in Table 3, along with the percent differ-
ence from the ion chamber measured dose.
The results of the calibration protocol comparison indicate that
similar results can be expected using either the CT‐based or mega-
voltage‐based calibration method. On average, the absolute differ-
ence between the dose determined using OSLD and one of these
two methods versus that determined directly using a CT ion cham-
ber was less than 5%.
The vendor‐recommended calibration shows good agreement with
the ion chamber for very low experimental energies (80 kVp). How-
ever, as the CT energy increases, the agreement between the OSLD
and the ion chamber deteriorates—exceeding 20% disagreement for
many scan techniques. Although the vendor energy correction factor
(1.19) was applied it does not appear adequate for the range of ener-
gies seen in clinically relevant scans. For the set of conditions exam-
ined in this study, the vendor‐recommended calibration technique
underestimated the dose by an average of 15.5%. This result is consis-
tent with the recent work by Vrieze et al.,29 who used the manufac-
turer‐recommended calibration procedure and found that the OSLD
systematically under‐responded relative to ion chamber readings.
Both the CT‐based calibration and the megavoltage‐based cali-
bration have been shown to be strong alternatives to the vendor‐
provided approach for calibrating OSLD nanoDots. Each of these
two methods provides a measure of dose well within 10% of a CT
ion chamber for a wide range of scan conditions. For the scan condi-
tions examined, a very specific energy correction factor was applied
to account for variations in the spectra between the calibration con-
ditions and the experimental conditions. Such precise spectral infor-
mation is rarely known for a particular measurement condition, and
energy correction factors based on more general scan parameters
(kVp, phantom size, scan extent, etc.) are more useful for clinical
application. The sensitivity of kQ to different scan parameters was
previously found to be most sensitive to kVp and measurement loca-
tion, and to be relatively insensitive to scan extent or phantom/pa-
tient size (usually less than a 2% effect).18 Consequently, values for
kQ can be well approximated based solely on nominal kVp and mea-
surement position with only a small increase in measurement uncer-
tainty. To determine recommended values for kQ for the CT‐based
calibration protocol, we averaged previously determined values of kQ
across different phantom sizes and scan extents.18 This provided
average kQ values based solely on kVp and measurement position
(Table 4).
For a calibration relative to a megavoltage beam, the value of kQ
is far from unity because of the large difference in energy between
calibration and measurement. Table 5 contains the recommended
values for kQ for this protocol based on the same pooling of previ-
ously determined kQ values
18 based solely on kVp and measurement
position. While these values were calculated specifically for 60Co,
they could also be used for 6 MV beams within 2%.7,20
TAB L E 2 Energy correction factor values for two different
calibration protocols.
Measurement
position kVp
Mean spectral
energy (keV) kQ,CT kQ,Co-60
1 80 45.4 0.82 0.29
2 80 47.9 0.85 0.30
3 120 51.7 0.88 0.31
4 120 54.7 0.91 0.33
5 120 55.3 0.93 0.33
6 140 58.1 0.97 0.35
7 140 58.7 0.96 0.34
8 120 59.5 1.00 0.36
9 120 60.7 1.02 0.36
10 140 63.2 1.06 0.38
11 140 64.9 1.09 0.39
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The values provided in Tables 4 and 5 allow for simple and accu-
rate energy correction using either of the two proposed calibration
protocols.
Because the spectra may vary between different scanner manu-
facturers, these values should be applied with caution. While many
CT scanners have similar spectra, Toshiba scanners have been
known to have a softer spectrum, and therefore will have a different
kQ correction factor relative to a distinct calibration beam (i.e., the
vendor's calibration beam or a megavoltage beam; e.g., kQ in
Table 5). A strength of the CT calibration procedure is that the cali-
bration and experimental readings can be done on the same CT
scanner. If the CT spectrum is inherently softer than evaluated in
this study, this will be substantially accounted for in the calibration
procedure and thereby mitigate the effect of a different calibration
CT spectrum. While this will help mitigate substantial uncertainty in
kQ from mapping between, for example, a
60Co beam and an arbi-
trary CT calibration beam (e.g., Table 5), the relative variations in the
spectrum of any CT beam (i.e., different beam hardening and
F I G . 3 . Comparison of three OSLD
measured doses (using different calibration
protocols) to ion chamber measured dose.
Error bars on each dataset represent the
total uncertainty for each measurement.
The shaded region represents the
uncertainty associated with the ion
chamber reading.
TAB L E 3 For 11 different measurement locations, the dose determined with a farmer‐type ion chamber is presented. This is compared to the
dose measured with OSLD using three independent calibration protocols.
Measurement
condition kVp
Mean spectral
energy (keV)
Ion chamber
Vendor calibration In‐air CT calibration 60Co calibration
Dose (mGy) Dose (mGy) % diff Dose (mGy) % diff Dose (mGy) % diff
1 80 45.4 31.8 30.4 4.4 30.8 3.2 30.5 4.2
2 80 47.9 28.1 26.6 5.6 27.9 0.8 27.5 2.1
3 120 51.7 29.8 26.3 11.7 28.6 4.0 28.2 5.4
4 120 54.7 28.7 24.5 14.6 27.5 4.0 27.9 2.7
5 120 55.3 34.1 28.4 16.7 32.6 4.3 32.3 5.1
6 140 58.1 33.7 26.5 21.5 31.7 5.9 32.0 5.0
7 140 58.7 34.2 27.4 19.9 32.5 4.9 32.2 5.9
8 120 59.5 36.3 29.4 18.9 36.4 0.2 36.6 0.9
9 120 60.7 27.1 23.0 15.2 29.0 6.9 28.6 5.5
10 140 63.2 34.1 27.1 20.7 35.4 3.9 35.5 4.1
11 140 64.9 32.1 25.5 20.7 34.3 6.8 34.3 6.9
Average 15.5 4.1 4.4
TAB L E 4 Values of energy correction factor kQ relative to the CT‐
based calibration protocol for a range of CT parameters.
kVp Surface
Periphery
(1 cm depth) Center
80 0.85 0.83 0.81
120 1.03 0.98 0.90
140 1.10 1.03 0.94
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scattering between the calibration and experimental dosimeters as
shown in Table 4) will nevertheless persist. The magnitude of these
differences may be similar to the values shown here in Table 4, but
they will not be identical.
3.B | Uncertainty analysis
There are both random and systematic uncertainties associated with
the determination of dose using this OSLD system. The uncertainties
arise from measurement imprecision in the OSLD signal as well as
uncertainties in the various correction factors applied to the signal.
When averaged over the three readings, and as detailed in Table 6,
the relative uncertainty in the corrected OSLD signal was consistent
regardless of the calibration protocol: 1.3%. This originated with the
relative uncertainty in the depletion‐corrected raw OSLD reading
(0.8%) and the relative uncertainty in the element specific sensitivity
factor (1.0%). The uncertainty in ND was dominated by the uncertainty
in the delivered dose to the standard dosimeters, which was lowest
for the megavoltage calibration protocol and produced an uncertainty
in ND,60Co of 1.6%. In contrast, the uncertainty in the calibration coeffi-
cient using the other two protocols had a value of slightly over 5%.
Finally, the total uncertainty in the dose determination using each pro-
tocol included the uncertainty in the correction factors. The largest
component of uncertainty in this step was from the beam quality cor-
rection factors. The relative uncertainty in the corrected OSLD read-
ing, the calibration coefficient, and the overall dose determination for
the three calibration protocols is shown in Table 6.
The largest overall uncertainty was associated with the vendor
calibration, largely because of the simplistic management of the
energy dependence of the detector. When comparing the CT and
the 60Co‐based protocols, the 60Co protocol had better precision in
the calibration coefficient, but because it had much larger correction
factors, it had a larger uncertainty associated with these correction
factors, leading to a slightly larger overall uncertainty.
The calibration protocol with the lowest overall uncertainty was
the CT‐based calibration, and this is likely the best calibration option
for most diagnostic CT clinics. The relative uncertainty in dose mea-
surement using properly calibrated OSLD is ±8.3% (2‐sigma), which is
reasonable for CT dosimetry applications. Precise dosimetry is also
achievable using a megavoltage calibration, and this approach may be
of interest to radiotherapy clinics due to their familiarity with mega-
voltage equipment. The relative uncertainty on the vendor calibration
protocol was the highest of the three examined. This is largely due to
the uncertainty in dose delivered to standards, as well as uncertainty
in the correction factor to account for energy or other effects. How-
ever, the vendor calibration is also sensitive to systematic uncertain-
ties; for example, as discussed above, the results will be systematically
different for a CT scanner with a different energy spectrum.
4 | CONCLUSION
In this work, two calibration protocols are presented which are
strong alternatives to the vendor‐supplied calibration method for
performing CT dosimetry using the nanoDot OSLD. The CT free‐
in‐air calibration requires a previously calibrated ion chamber, and
OSLD standards to be irradiated with a consistent and reproducible
scan technique. Energy correction factors are generally necessary
using this calibration technique and a simple table of factors is pro-
vided that cover a wide range of scan conditions. The megavoltage
calibration requires a larger correction factor, but offers comparable
accuracy. Using either the CT free‐in‐air or megavoltage‐based cali-
bration approaches, point dosimetry with a relative uncertainty of
less than ±10% is readily achievable in a CT environment.
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